X-154379486-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_000117.3(EMD):c.2T>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000117.3 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 26
ClinVar
Submissions by phenotype
X-linked Emery-Dreifuss muscular dystrophy Pathogenic:1
This sequence change affects the initiator methionine of the EMD mRNA. The next in-frame methionine is located at codon 73. This variant is not present in population databases (ExAC no frequency). Disruption of the initiator codon has been observed in individual(s) with Emery-Dreifuss muscular dystrophy (PMID: 9266737, 10382909, 7894480). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.